President of All-Russia Business Association “Delovaya Rossiya” (“Business Russia”), Member of the Public Chamber of the Russian Federation, Chairman of the Board R-Pharm.
Born in Moscow, Russia on 27 August 1979.
Graduated from the State University “Higher School of Economics”, Diploma in Economy and Business Administration.
Since 1995 in Healthcare and Pharmaceutics.
R-Pharm Group is high-tech pharmaceutical enterprise and one of the leaders of the Russian pharmaceutical market. It was founded in 2001. In 2017, 10% of JSC R-Pharm’s shares were acquired by Japanese Corporation Mitsui & Co., Ltd. The mission of R-Pharm is to increase the accessibility of the most modern medicines for patients in Russia and all over the world.
The staff consists of more than 3,000 highly qualified professionals. The group of companies operates throughout the Russian Federation, CIS member states, USA, Germany, Japan and other countries. There are more than 70 branches and representative offices. R-Pharm’s headquarters are located in Moscow.
R-Pharm specializes in research and development, manufacturing of high-tech medicines, as well as the distribution of laboratory supplies and medical equipment. Various Russian leading medical institutions and organizations are among the clients of the group.
R-Pharm Group owns several state-of-the-art manufacturing sites in Russia and abroad: high-tech packaging site in Kostroma region, a plant for production of finished dosage forms and biotechnological APS in Yaroslavl, pilot manufacturing site in Moscow, a plant for production of solid dosage forms in Illertissen (Germany). A modern research and APS manufacturing site in Rostov and Russian-Azerbaijani pharmaceutical plant in Baku are under construction. In 2018 R-Pharm and Rosatom agreed to create a joint manufacturing plant in Moscow.
R-Pharm has its own research and development facilities, which allows it to conduct various activities in partnership with the leading Russian and foreign academic institutes.
R-Pharm signed numerous agreements on product manufacturing localization, technology transfer and licensing with the biggest pharmaceutical companies from all over the world.
The portfolio of the group includes medicines for various therapeutic areas : oncological, hematologic, cardiological, immunological, antibacterial, antiviral, including HIV therapy, pharmaceuticals used during and after organ transplantation, treatment of multiple sclerosis, hemophilia, as well as muscle relaxants, contrast agents and anesthetics.
Alexey Repik has established and continues investing his efforts and personal funds in training scientific brainpower and highly-qualified healthcare personnel:
The "Scholarship on the development of pharmaceutical industry" project has been developing for 5 years. Within this period more than 500 bright students and promising young specialists from Saint Petersburg, Kazan, Volgograd, Yaroslavl, Tomsk, Kostroma, and Perm received educational grants and had practice at R-Pharms facilities.
In May 2012 the Supervisory Board of the Strategic Initiative Agency on the Development of New Projects under the chairmanship of the President of the Russian Federation Vladimir Putin approved the joint master's program of R-Pharm and Tomsk Polytechnic University named "Academy of pharmaceutical and biotechnological industry".
The company has been implementing an extensive education and training program for talented Russian students and young scientists in Germany, Switzerland, Belgium, the USA, Japan and China.
Co-Chairman of All-Russia Business Association “Delovaya Rossiya” (“Business Russia”), actively participating in the improvement of investment climate in the Russian Federation and the establishment of the regional investment standard.
Member of the Economic Council under the President of the Russian Federation.
Member of the Presidential Council for Priority National Projects and Demographic Policy.
Member of the National Council under the President of the Russian Federation for Vocational Qualifications.
Member of the Expert Council under the Government of the Russian Federation.
Member of the Public Chamber of the Russian Federation, Head of Commission on Investment Climate.
Representative (public ombudsman) of the Commissioner of the Presidential Council on the protection of the rights of entrepreneurs on issues related to the protection of the rights of foreign investors.
Board-member and Co-chairman of Committee of the Russian Union of Industrialists and Entrepreneurs on pharmaceutical and medical industry.
Co-Chairman of the National Rating Committee
Member of the Public Council under the Ministry of Industry and Trade of the Russian Federation (pharmaceutical, medical equipment and technologies).
Member of the Supervisory Board of the Autonomous Nonprofit Organization "Agency for Strategic Initiatives to promote new projects".
Head of work group on development of roadmap “Creation of national framework of competences and qualifications” in terms of national business initiative on enhancement of investment climate in Russia.
Member of the Expert Board at the Federal Antimonopoly Service of Russia on Competition Development in Social Sphere and Healthcare.
Member of the Association of Russian Pharmaceutical Manufacturers.
Member of the Board of the Managers' Association.
Head of all-Russian public organization "Russian Association of Public Oversight"
Participant and partner of the International Pharmaceutical Manufacturers Association, Japan ROTOBO association, Russian-German Chamber of Commerce, the Swiss Biotech association.